The market is segmented based on Segmentation, By Type (Plain Old Balloon Angioplasty, Drug-Coated Balloon (DCB) Angioplasty, Cutting Balloons, Scoring Balloons, and Stent Graft Balloon Catheter), Material (Nylon, Polyurethane, Silicone Urethane Co-Polymers, and Other), Balloon Type (Semi-Compliant and Non-Compliant), Disease Indication (Coronary Angioplasty, Venous Angioplasty, Carotid Angioplasty, Renal Artery Angioplasty, and Peripheral Angioplasty), End User (Cath Labs, Hospitals, Specialty Clinics, Ambulatory Surgery Centers, and Diagnostic Centers) – Industry Trends and Forecast to 2032
.
The Global Angioplasty Balloons Market size was valued at USD 3.12 USD Billion in 2024.
The Global Angioplasty Balloons Market is projected to grow at a CAGR of 4.3% during the forecast period of 2025 to 2032.
The major players operating in the market include Medtronic, BD, Boston Scientific Corporation, Abbott, AngioDynamics, B. Braun Melsungen AG., Biomerics, BIOTRONIK Vertriebs GmbH & Co. KGCook, Cardinal Health, Hexacath, JOTEC GmbH, CTK biotechInc, Koninklijke Philips N.V.., MicroPort Scientific Corporation, Nipro Medical Corporation, Palex Medical SA, Panmed US, Stryker, Teleflex Incororated and Terumo Corporation .
The market report covers data from the U.S., Canada and Mexico, Germany, France, U.K., Italy, Russia, Spain, Denmark, Sweden, Norway, Rest of Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Nigeria, Egypt, Kuwait, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.